Get the Stockscreener App
2.78
1.09%
0.03
After Hours:
3.20
0.42
+15.11%
Painreform Ltd stock is traded at $2.78, with a volume of 3.82M.
It is up +1.09% in the last 24 hours and up +24.11% over the past month.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
See More
Previous Close:
$2.75
Open:
$2.64
24h Volume:
3.82M
Relative Volume:
4.05
Market Cap:
$1.64M
Revenue:
-
Net Income/Loss:
$-9.34M
P/E Ratio:
-0.3061
EPS:
-9.0833
Net Cash Flow:
$-6.69M
1W Performance:
-6.40%
1M Performance:
+24.11%
6M Performance:
-83.45%
1Y Performance:
-95.15%
1-Day Range:
$2.58
$3.04
1-Week Range:
$2.51
$3.11
52-Week Range:
$1.7272
$80.64
Painreform Ltd Stock (PRFX) Company Profile
Compare PRFX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRFX
Painreform Ltd
|
2.78 | 1.64M | 0 | -9.34M | -6.69M | -7.14 |
|
ZTS
Zoetis Inc
|
175.25 | 79.07B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.66 | 43.68B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.62 | 43.18B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.01B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
13.09 | 15.62B | 15.05B | -883.30M | 1.89B | -0.74 |
Painreform Ltd Stock (PRFX) Latest News
Fastly Inc (FSLY)’S -0.38% Retreat Makes It Worth Considering Again - Stocks Register
Grupo Supervielle S.A. ADR (SUPV): Worth A Small Bite At $11.39 - Stocks Register
SmartRent Inc (SMRT) Offers An Excellent Investment Opportunity At Current Levels - Stocks Register
3 Penny Stocks to Watch Now, 11/21/24 - TipRanks
Crude Oil Moves Lower; Williams-Sonoma Shares Gain After Q3 Results - Benzinga
Nasdaq Tumbles Over 100 Points; TJX Earnings Top Views - Benzinga
US Stocks Mostly Lower; Target Posts Downbeat Earnings - Benzinga
PainReform’s PRF-110 Shows Promise in Initial Trial Results - TipRanks
PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial - GlobeNewswire
PainReform's PRF-110 Shows Early Success in Phase 3 Pain Trial, Data Issues Persist | PRFX Stock News - StockTitan
"Stocks Under $1 to Watch: SOAR, PRFX, NCNC, BTTC, RJDG-Breakthroughs, Surges, Market Movers!" - openPR
Gold Moves Higher; Medtronic Posts Upbeat Results - Benzinga
PainReform Stock Is Soaring Tuesday: What's Going On? - Benzinga
Stock Market News: PainReform surges by 130.26% whereas QMMM Holdings declines by 28.03% during mid day trading - Business Upturn
Nasdaq Gains 100 Points; Lowe's Earnings Beat Views - Benzinga
Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket - Benzinga
PainReform Announces 1-for-4 Reverse Share Split - TipRanks
Armistice Capital, LLC's Strategic Acquisition in PainReform Ltd - GuruFocus.com
PainReform faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Australia
PainReform receives Nasdaq notice regarding minimum stockholders’ equity requirement - MSN
PRFXPainReform Ltd. Ordinary Shares Latest Stock News & Market Updates - StockTitan
PainReform faces Nasdaq delisting over equity shortfall - Investing.com India
PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement - GlobeNewswire
PRFX stock touches 52-week low at $0.53 amid sharp annual decline - Investing.com India
PainReform cut to Hold at Maxim amid ‘changed’ market dynamics - Yahoo Finance
Maxim cuts PainReform stock rating to Hold from Buy post FDA update - Investing.com India
Maxim cuts PainReform stock rating to Hold from Buy post FDA update By Investing.com - Investing.com South Africa
PainReform (NASDAQ:PRFX) Shares Up 11% – Here’s Why - Defense World
PainReform Announces Significant Share Offering - TipRanks
Elanco Animal Health (ELAN) Stock Drops 5% Amidst Industry Decli - GuruFocus.com
What You Didn’t Know About PainReform Ltd (NASDAQ: PRFX) This Week - Stocks Register
When Would Be The Best Time To Buy SBA Communications Corp (NASDAQ: SBAC) Stock? - Stocks Register
What You Didn’t Know About Crown Castle Inc (NYSE: CCI) This Week - Stocks Register
PainReform Calls Shareholder Meeting for Key Votes - TipRanks
PainReform Shareholders Approve All Proposals - TipRanks
Prestige Wealth Inc. (NASDAQ:PWM) Sees Significant Drop in Short Interest - Defense World
PainReform Ltd. (NASDAQ:PRFX) Short Interest Up 2,221.4% in September - Defense World
Insider’s View: Deciphering PainReform Ltd (PRFX)’s Financial Health Through Ratios - The Dwinnex
US Stocks Edge Higher; Chicago Fed National Activity Increases In August - Benzinga
PainReform Ltd (PRFX)’s results reveal risk - US Post News
Why Granite Point Mortgage Trust Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
PainReform Ltd [PRFX] Is Currently 4.40 below its 200 Period Moving Avg: What Does This Mean? - The DBT News
Was there any good news for PainReform Ltd (PRFX) stock in the last session? - US Post News
Navigating PRFX’s Stock Market Maze: Ups and Downs in 2023 - The InvestChronicle
PRFX stock touches 52-week low at $0.74 amid sharp annual decline - Investing.com
Financial Health Check: Examining PainReform Ltd (PRFX)’s Key Ratios - The Dwinnex
United States shares mixed at close of trade; Dow Jones Industrial Average down 0.23% - MSN
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.23% - MSN
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.23% - MSN
PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110 - GlobeNewswire
Painreform Ltd Stock (PRFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
0.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):